EMA Authorised: Litfulo (ritlecitinib tosilate) — Pfizer Europe MA EEIG

View source ↗

Summary

The European Medicines Agency authorised Litfulo (ritlecitinib tosilate) from Pfizer Europe MA EEIG for the treatment of alopecia areata in the European Union, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Litfulo (deucravacitinib)

Snippet

Status: Authorised. Therapeutic area: Alopecia Areata. MAH: Pfizer Europe MA EEIG. Decision date: 26/02/2025